ChatGPT and generative AI land in pharma marketing with sense of awe — and plenty of caution
AI has arrived and the Pharma industry needs to step enthusiastically into the future while building guiderails and protocols to keep the output both factual and safe. Generative AI is bringing great leaps forward in generating content at speed and volume and both agencies and pharma companies can benefit provided that they understand the risks. Our Innovation Director Simon Wilson explains some of the issues and shares his experience (and his most recent avatar) in this discussion with Endpoints News (subscription required).
